Drug Pricing

Recent

1 article

Business· Jan 21, 2020

Drug Companies Are Focusing on the Poor After Decades of Ignoring Them

After years of chasing wealthy markets, big drugmakers are courting low-income patients with tiered prices and access programs. The question is whether the shift is conscience, strategy, or both.

This topic page is new. We’ll add an editorial introduction and additional coverage as the section grows. Browse the archive in the meantime.

Stay close to the work

A short daily briefing in your inbox, or follow along on the platform you already use.

Unsubscribe whenever. We never share your email.

Or follow along